Nurse Practitioner, Family · Staten Island, NY
NPI
1962120659
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
22 Krissa Ct
Staten Island, NY, 10312
Phone (646) 275-0726
Groups this clinician bills Medicare through
Medicare paid, 2024
$396K
5,768 services
Medicare patients, 2024
423
Average age 76
Drug cost, 2024
$861K
2,785 prescriptions
Company payments, 2025
$366
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Stoin was code 64566 (musculoskeletal), 2,829 times for 269 patients. In total Anna Stoin billed 5,768 services in 23 codes, and Medicare paid $396K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64566 Musculoskeletal | Office | 2,829 | 269 | $92.38 | $261K |
| 99213 Office E&M - Established | Office | 813 | 344 | $70.13 | $57K |
| 99212 Office E&M - Established | Office | 313 | 191 | $43.94 | $14K |
| 81002 Clinical Chemistry | Office | 276 | 226 | $3.41 | $941 |
| 97032 PT Treatment | Office | 242 | 54 | $8.84 | $2,140 |
| 36415 Venipuncture Blood Collection | Office | 223 | 189 | $8.65 | $1,929 |
| 97750 Occupational Therapy | Office | 213 | 48 | $25.86 | $5,509 |
| 90912 Behavioral Health Services | Office | 189 | 48 | $62.43 | $12K |
| 90913 Behavioral Health Services | Office | 185 | 46 | $24.50 | $4,532 |
| 99203 Office E&M - New | Office | 107 | 107 | $86.53 | $9,259 |
| 51784 Neurologic | Office | 106 | 89 | $42.65 | $4,521 |
| 51798 Ultrasound - Nonspecific | Office | 78 | 60 | $10.64 | $830 |
| 51741 Test - Miscellaneous | Office | 73 | 56 | $7.94 | $580 |
| 91122 Test - Miscellaneous | Office | 57 | 47 | $215.88 | $12K |
| 55899 Other Organ Systems | Office | 35 | 31 | $213.80 | $7,483 |
By year: 2022 $6,348 for 71 services; 2023 $193K for 2,541 services; 2024 $396K for 5,768 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 276 | 226 | $3.41 | $941 |
| 36415 Venipuncture Blood Collection | 223 | 189 | $8.65 | $1,929 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Stoin prescribed most often to Medicare patients was Gemtesa (Vibegron), with 1,004 prescriptions and refills. In total Anna Stoin wrote 2,785 Medicare prescriptions that cost $861K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 1,004 | 1,262 | 204 | $571K |
| Myrbetriq Mirabegron | 522 | 523 | 80 | $225K |
| Tamsulosin Hcl Generic | 460 | 555 | 107 | $2,651 |
| Finasteride Generic | 170 | 194 | 34 | $837 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 111 | 111 | 61 | $1,528 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 108 | 170 | 30 | $1,465 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 91 | 93 | 26 | $635 |
| Premarin Estrogens, Conjugated | 62 | 102 | 29 | $26K |
| Ciprofloxacin Hcl Generic | 52 | 52 | 44 | $124 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 24 | 24 | 20 | $60.27 |
| Rapaflo Silodosin | 19 | 19 | Under 11 | $4,765 |
| Dutasteride Generic | 16 | 16 | Under 11 | $173 |
| Toviaz Fesoterodine Fumarate | 16 | 16 | Under 11 | $4,449 |
| Uroxatral Alfuzosin Hcl | 14 | 14 | Under 11 | $10K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 13 | 13 | 13 | $84.92 |
Brand drugs: 1,686 claims; generic drugs: 1,099 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Stoin $366 ($366 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sumitomo Pharma America, Inc. with $185.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.